BriaCell Therapeutics: Interview With CEO Dr. William Williams About Cancer Immunotherapy And Off-The-Shelf Cancer Vaccines
· pulse2.com · popularity 18/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at pulse2.com →
Summary
BriaCell Therapeutics is a clinical-stage biotechnology company developing targeted, off-the-shelf cellular immunotherapies for cancer, including its lead Bria-IMT candidate currently undergoing a pivotal Phase 3 clinical trial for metastatic breast cancer. Pulse 2.0 interviewed BriaCell Therapeutics CEO Dr. William Williams to learn more about his background, the company's origins, its cancer immunotherapy platform, clinical research, competitive advantages, and plans to expand its treatments across multiple solid tumor types. The post BriaCell Therapeutics: Interview With CEO Dr. William Williams About Cancer Immunotherapy And Off-The-Shelf Cancer Vaccines appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 10.